TY - JOUR
T1 - Decreased density of CD3+ tumor-infiltrating lymphocytes during gastric cancer progression
AU - Arigami, Takaaki
AU - Uenosono, Yoshikazu
AU - Ishigami, Sumiya
AU - Matsushita, Daisuke
AU - Hirahara, Tetsushi
AU - Yanagita, Shigehiro
AU - Okumura, Hiroshi
AU - Uchikado, Yasuto
AU - Nakajo, Akihiro
AU - Kijima, Yuko
AU - Natsugoe, Shoji
PY - 2014/7
Y1 - 2014/7
N2 - Background and Aim: Tumor cells escape host immunosurveillance and thus produce an advantageous environment for tumor progression. Recent studies have demonstrated that tumor-infiltrating lymphocytes (TILs) play a principal role in the immune response to tumors. However, little is understood about numerical alterations in CD3+ TILs during tumor progression in patients with gastric cancer. The present study examines the density of CD3+ TILs to elucidate their clinical significance in gastric cancer. Methods: The numbers of CD3+ TILs in 120 resected specimens from patients with gastric cancer and 27 endoscopic resected specimens from patients with gastric adenoma were immunohistochemically assessed using a CD3 polyclonal antibody. Results: The mean number of CD3+ TILs (±SD) in the patients with gastric cancer and adenoma was 87.5±59.8 and 379.6±128.1, respectively. Significantly more CD3+ TILs were found in specimens from patients with gastric adenoma than with gastric cancer (P<0.0001). The numbers of CD3+ TILs significantly correlated with depth of tumor invasion, lymph node metastasis, and stage (P=0.022, P=0.0004, and P=0.011, respectively). The 5-year survival rate was significantly poorer for patients with fewer CD3+ TILs (P=0.004). Multivariate analysis selected the density of CD3+ TILs as an independent prognostic factor (P=0.034). Conclusions: Our results demonstrated that the density of CD3+ TILs decreases during tumor progression. The density of CD3+ TILs is an immunological predictor of lymph node metastasis and disease outcome in patients with gastric cancer.
AB - Background and Aim: Tumor cells escape host immunosurveillance and thus produce an advantageous environment for tumor progression. Recent studies have demonstrated that tumor-infiltrating lymphocytes (TILs) play a principal role in the immune response to tumors. However, little is understood about numerical alterations in CD3+ TILs during tumor progression in patients with gastric cancer. The present study examines the density of CD3+ TILs to elucidate their clinical significance in gastric cancer. Methods: The numbers of CD3+ TILs in 120 resected specimens from patients with gastric cancer and 27 endoscopic resected specimens from patients with gastric adenoma were immunohistochemically assessed using a CD3 polyclonal antibody. Results: The mean number of CD3+ TILs (±SD) in the patients with gastric cancer and adenoma was 87.5±59.8 and 379.6±128.1, respectively. Significantly more CD3+ TILs were found in specimens from patients with gastric adenoma than with gastric cancer (P<0.0001). The numbers of CD3+ TILs significantly correlated with depth of tumor invasion, lymph node metastasis, and stage (P=0.022, P=0.0004, and P=0.011, respectively). The 5-year survival rate was significantly poorer for patients with fewer CD3+ TILs (P=0.004). Multivariate analysis selected the density of CD3+ TILs as an independent prognostic factor (P=0.034). Conclusions: Our results demonstrated that the density of CD3+ TILs decreases during tumor progression. The density of CD3+ TILs is an immunological predictor of lymph node metastasis and disease outcome in patients with gastric cancer.
UR - http://www.scopus.com/inward/record.url?scp=84904306854&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84904306854&partnerID=8YFLogxK
U2 - 10.1111/jgh.12551
DO - 10.1111/jgh.12551
M3 - Article
C2 - 25587614
AN - SCOPUS:84904306854
SN - 0815-9319
VL - 29
SP - 1435
EP - 1441
JO - Journal of Gastroenterology and Hepatology (Australia)
JF - Journal of Gastroenterology and Hepatology (Australia)
IS - 7
ER -
